Cytosolic DNA sensor activation inhibits HIV infection of macrophages.
Biao ZhangJin-Biao LiuLina ZhouXu WangShazheb KhanWen-Hui HuWen-Zhe HoPublished in: Journal of medical virology (2022)
Cytosolic recognition of microbial DNA in macrophages results in the activation of the interferon (IFN)-dependent antiviral innate immunity. Here, we examined whether activating DNA sensors in peripheral blood monocyte-derived macrophages (MDMs) can inhibit human immunodeficiency virus (HIV). We observed that the stimulation of MDMs with poly(dA:dT) or poly(dG:dC) (synthetic ligands for the DNA sensors) inhibited HIV infection and replication. MDMs treated with poly(dA:dT) or poly(dG:dC) expressed higher levels of both type I and type III IFNs than untreated cells. Activation of the DNA sensors in MDMs also induced the expression of the multiple intracellular anti-HIV factors, including IFN-stimulated genes (ISGs: ISG15, ISG56, Viperin, OAS2, GBP5, MxB, and Tetherin) and the HIV restriction microRNAs (miR-29c, miR-138, miR-146a, miR-155, miR-198, and miR-223). In addition, the DNA sensor activation of MDM upregulated the expression of the CC chemokines (RANTES, MIP-1α, MIP-1β), the ligands for HIV entry coreceptor CCR5. These observations indicate that the cytosolic DNA sensors have a protective role in the macrophage intracellular immunity against HIV and that targeting the DNA sensors has therapeutic potential for immune activation-based anti-HIV treatment.
Keyphrases
- antiretroviral therapy
- human immunodeficiency virus
- circulating tumor
- hiv infected
- hiv positive
- cell proliferation
- hepatitis c virus
- cell free
- long non coding rna
- hiv testing
- single molecule
- hiv aids
- dendritic cells
- long noncoding rna
- men who have sex with men
- poor prognosis
- peripheral blood
- nucleic acid
- adipose tissue
- circulating tumor cells
- immune response
- drug delivery
- microbial community
- induced apoptosis
- reactive oxygen species
- drug induced
- regulatory t cells
- genome wide
- combination therapy
- endothelial cells
- replacement therapy